Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Endonovo Therapeutics, Inc./ 1-A/A

SEC Filing · 1-A/A

Endonovo Therapeutics, Inc.

ENDVOTCEQUITYCurrent

SEC Filing

Filed Aug 25, 2023Accepted Aug 25, 2023, 3:04 AM EDTCIK 1528172Accession 0001493152-23-030138
View company →Permanent SEC source ↗
Share

Company context

Current securities

ENDVOTC · EQUITY · Current

Recent company filings

  1. SEC STAFF ACTION filingSep 19, 2024
  2. 15-12G filingFeb 2, 2024
  3. 8-K filingJan 3, 2024
  4. 10-Q/A filingDec 29, 2023
  5. 10-Q filingDec 29, 2023

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗